IRIS UniCatt

Innocenti, Idanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.104
AS - Asia 4.263
EU - Europa 3.229
SA - Sud America 934
AF - Africa 111
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 13.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.975
SG - Singapore 1.861
CN - Cina 1.050
BR - Brasile 751
IT - Italia 686
SE - Svezia 635
DE - Germania 542
VN - Vietnam 454
FR - Francia 378
IE - Irlanda 181
IN - India 172
GB - Regno Unito 162
FI - Finlandia 156
BD - Bangladesh 136
UA - Ucraina 136
ID - Indonesia 130
JP - Giappone 112
RU - Federazione Russa 93
HK - Hong Kong 81
AR - Argentina 72
PL - Polonia 71
CA - Canada 60
TR - Turchia 45
MX - Messico 43
IQ - Iraq 36
KR - Corea 35
EC - Ecuador 30
NL - Olanda 30
AT - Austria 28
CI - Costa d'Avorio 27
ES - Italia 25
BE - Belgio 24
ZA - Sudafrica 21
CO - Colombia 19
PK - Pakistan 18
UZ - Uzbekistan 17
VE - Venezuela 17
PY - Paraguay 16
MA - Marocco 15
CZ - Repubblica Ceca 13
CL - Cile 12
IL - Israele 12
IR - Iran 12
SA - Arabia Saudita 12
CH - Svizzera 10
DZ - Algeria 9
EG - Egitto 9
KE - Kenya 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
TN - Tunisia 8
BG - Bulgaria 7
BO - Bolivia 7
GR - Grecia 7
KZ - Kazakistan 7
JO - Giordania 6
OM - Oman 6
BA - Bosnia-Erzegovina 5
BB - Barbados 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
SN - Senegal 5
XK - ???statistics.table.value.countryCode.XK??? 5
AZ - Azerbaigian 4
HU - Ungheria 4
KW - Kuwait 4
LK - Sri Lanka 4
QA - Qatar 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
LB - Libano 3
NI - Nicaragua 3
UY - Uruguay 3
AU - Australia 2
BH - Bahrain 2
CY - Cipro 2
DK - Danimarca 2
GY - Guiana 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
RS - Serbia 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 13.632
Salva come PNG Salva come JPEG
Città #
Singapore 924
Chandler 666
San Jose 504
Ashburn 471
Beijing 241
Dublin 176
Rome 171
Ho Chi Minh City 143
Lauterbourg 133
Los Angeles 129
Jakarta 117
New York 116
Hanoi 115
Dearborn 112
Hefei 108
Jacksonville 103
San Mateo 103
Tokyo 98
Wilmington 96
Ann Arbor 93
Council Bluffs 89
Frankfurt am Main 82
Munich 79
Cattolica 76
Chicago 74
Dallas 74
Nanjing 73
Hong Kong 72
Boston 71
Hyderabad 70
Milan 70
Warsaw 64
Florence 62
Marseille 61
Princeton 61
Helsinki 58
Fairfield 55
São Paulo 53
Houston 50
Woodbridge 50
Moscow 49
Buffalo 48
Lancaster 46
Seattle 41
Boardman 39
Nanchang 39
Tukwila 36
Bremen 35
Lappeenranta 34
Santa Clara 34
Orem 33
Seoul 33
The Dalles 33
Brooklyn 32
Lawrence 30
Turku 30
Rio de Janeiro 28
Abidjan 27
Kunming 27
Shanghai 27
Kent 26
Redwood City 25
Brussels 24
Naples 23
Paris 23
Shenyang 23
Tianjin 23
Atlanta 21
Cambridge 21
Stockholm 21
Da Nang 20
London 20
Nuremberg 18
Phoenix 18
Albany 17
Düsseldorf 17
Izmir 17
Mexico City 17
Minneapolis 17
Redmond 17
Tashkent 17
Vienna 17
St Louis 16
Toronto 16
Biên Hòa 15
Guangzhou 15
Johannesburg 15
Pune 15
Tampa 15
Washington 15
Zhengzhou 15
Dhaka 14
Elk Grove Village 14
Haiphong 14
Norwalk 14
Nürnberg 14
Auburn Hills 13
Baghdad 13
Denver 13
Mountain View 13
Totale 7.365
Salva come PNG Salva come JPEG
Nome #
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 332
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR 224
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 221
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 211
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 188
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 179
Chemoprevention of lung pathologies by dietary n-3 polyunsaturated fatty acids. 174
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 170
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 166
Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. 166
The effects of omega-3 polyunsaturated fatty acids against cancer 161
Role of microRNAs in Chronic Lymphocytic Leukemia 160
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 153
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 151
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia 149
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 146
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 146
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: Correlation with biologically-based risk stratification 144
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 141
Mycosis fungoides as a cause of severe obstructive sleep apnea 139
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 138
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 137
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 132
Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units 130
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 130
Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics 125
What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study 123
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma 123
Clinical, pathological, and biological characterization of Richter syndrome developing after ibrutinib treatment for relapsed chronic lymphocytic leukemia 123
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 123
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cells 122
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 122
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. 121
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients 121
What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? 119
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 117
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 116
Unrelated cord blood transplantation and post-transplant cyclophosphamide 115
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody? 115
Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers 113
Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience 113
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments. 112
the concomitance of lymphoma and breast carcinoma in the bone 112
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 112
Effect of HLA mismatch on post-transplant infections in allogeneic hematopoietic stem cell transplantation with PTCy-based GvHD prophylaxis 111
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 111
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real-life experience 108
Chlorambucil PLUS Rituximab As FRONT-LINE THERAPY in Elderly or Unfit Patients Affected by B-CELL Chronic Lymphocytic Leukemia: Results of A Single-Centre Retrospective Analysis 108
Second haploidentical stem cell transplantation for primary graft failure 107
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 105
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia 103
HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxis. 103
Remission of acquired von Willebrand syndrome in a patient with chronic lymphocytic leukemia treated with venetoclax 103
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region 103
Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. 103
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience 102
Richter transformation in Chronic Lymphocytic Leukemia 102
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 102
Safety and efficacy of SARS-Cov2 neutralizing monoclonal antibodies after stem cell transplant or CAR-T cell infusion 101
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 100
Treatment options for elderly/unfit patients with chronic lymphocytic leukemia in the era of targeted drugs: A comprehensive review 100
Unrelated cord blood transplantation and post-transplant cyclophosphamide 99
Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed 97
Chronic Lymphocitic Leukaemia: Census of Patients Treated in Italian Haematology Units 97
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab 97
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 97
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 96
BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 95
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience 95
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 95
Validation of the CLL-IPI and comparison with the MDACC prognostic index: analysis of 1364 newly diagnosed patients 94
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia 94
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas 93
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 92
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T‐cells (CAR‐T): A comprehensive review on incidence, risk factors and current management 92
Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study 92
The concomitance of lymphoma and breast carcinoma in the bone 92
Blinatumomab as a successful and safe therapy in Down syndrome patients with relapsed/refractory b-precursor acute lymphoblastic leukaemia: Case reports and literature review 91
B-cell receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter transformation 91
Days alive outside hospital and readmissions in patients undergoing allogeneic transplants from identical siblings or alternative donors 91
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 90
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience 90
VEGF and IL-6 Correlation in POEMS: A Potential Upcoming Marker of Active Disease and Early Autologous BMT Response 89
Autologous peripheral blood stem cell transplantation and the role of lenalidomide in patients affected by poems syndrome 88
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia 87
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: A comprehensive review 86
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategies 86
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab 85
Relapsed/refractory pure red cell aplasia in chronic lymphocytic leukemia successfully treated with acalabrutinib: a case report and review of the literature 85
Preoperative autologous blood donation in adult bone marrow donors: reappraisal of a single-centre experience 84
Efficacy of ibrutinib in late relapse chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation 84
Second haploidentical stem cell transplantation for primary graft failure 83
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study 82
Purging with chlorambucil to prevent infusion-related reaction before obinutuzumab administration: A monocentric pilot experience 82
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 82
Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role 81
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort 80
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience 80
Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience 79
Non-overt disseminated intravascular coagulopathy associated with the first obinutuzumab administration in patients with chronic lymphocytic leukemia 78
Totale 11.678
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022763 61 27 27 38 56 14 9 115 31 40 182 163
2022/20231.857 254 250 133 259 145 238 107 137 208 43 64 19
2023/20241.010 45 268 63 64 41 147 69 34 18 42 106 113
2024/20252.227 49 69 145 77 179 68 67 87 271 259 577 379
2025/20265.863 805 199 386 689 895 328 943 339 412 422 224 221
2026/202764 64 0 0 0 0 0 0 0 0 0 0 0
Totale 13.891